FinTrust Capital Advisors’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$59 Hold
10
﹤0.01% 1359
2024
Q2
$47 Hold
10
﹤0.01% 1360
2024
Q1
$44 Hold
10
﹤0.01% 1259
2023
Q4
$49 Hold
10
﹤0.01% 1241
2023
Q3
$60 Hold
10
﹤0.01% 1217
2023
Q2
$95 Hold
10
﹤0.01% 1181
2023
Q1
$95 Hold
10
﹤0.01% 1170
2022
Q4
$94 Hold
10
﹤0.01% 1168
2022
Q3
$0 Hold
10
﹤0.01% 1213
2022
Q2
$0 Buy
+10
New +$250 ﹤0.01% 1199
2021
Q4
Sell
-8
Closed -$1K 1173
2021
Q3
$1K Hold
8
﹤0.01% 1119
2021
Q2
$1K Sell
8
-200
-96% -$17.3K ﹤0.01% 1136
2021
Q1
$19K Sell
208
-4
-2% -$447 0.01% 727
2020
Q4
$18K Buy
212
+204
+2,550% +$14.9K 0.01% 704
2020
Q3
$0 Hold
8
﹤0.01% 1130
2020
Q2
$1K Hold
8
﹤0.01% 995
2020
Q1
$1K Sell
8
-69
-90% -$12.3K ﹤0.01% 1050
2019
Q4
$20K Buy
77
+69
+863% +$25.7K 0.01% 630
2019
Q3
$4K Hold
8
﹤0.01% 900
2019
Q2
$8K Hold
8
﹤0.01% 760
2019
Q1
$9K Sell
8
-26
-76% -$23.3K ﹤0.01% 791
2018
Q4
$21K Buy
+34
New +$25.1K 0.01% 578

Other funds holding ACB

FinTrust Capital Advisors's ACB Position: Q3 2024 in Review

FinTrust Capital Advisors held its Aurora Cannabis (ACB) position steady in Q3 2024 at 10 shares worth $59. The position accounts for ﹤0.01% of the portfolio, ranked #1359.

FinTrust Capital Advisors first reported a position in ACB in Q4 2018 and has held it in 22 quarters since. The position peaked at $21K in Q4 2018. 145 funds tracked by Wall St. Rank hold ACB as of Q3 2024.

  • FinTrust Capital Advisors held 10 shares of Aurora Cannabis worth $59 as of Q3 2024.
  • FinTrust Capital Advisors left its Aurora Cannabis share count unchanged in Q3 2024.
  • Aurora Cannabis made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #1359 holding.
  • FinTrust Capital Advisors first reported a position in Aurora Cannabis in Q4 2018 and has held it in 22 quarters since.
  • FinTrust Capital Advisors's Aurora Cannabis position peaked at $21K in Q4 2018.
  • 145 funds tracked by Wall St. Rank held Aurora Cannabis as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.